|
1
|
Castellino A, Tun AM, Wang Y, Habermann
TM, King RL, Ristow KM, Cerhan JR, Inwards DJ, Paludo J, Ansell SM,
et al: Clinical characteristics and outcomes of primary versus
secondary gastrointestinal mantle cell lymphoma. Blood Cancer J.
11:82021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lamm W, Dolak W, Kiesewetter B,
Simonitsch-Klupp I, Puhr H and Raderer M: Gastrointestinal
involvement in patients with mantle cell lymphoma: A single center
experience of eighty-five patients. Dig Dis. 37:194–200. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mohy-Ud-Din N, Guha A and Mitre M:
Complete endoscopic and histopathological remission of mantle cell
lymphoma of the gastrointestinal tract. Cureus.
11:e43502019.PubMed/NCBI
|
|
4
|
Zheng QF, Li JY, Qin L, Wei HM, Cai LY and
Nong B: Gastrointestinal involvement by mantle cell lymphoma
identified by biopsy performed during endoscopy: A case report.
Medicine (Baltimore). 97:e97992018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang PJ, Chang CL and Suk FM: Polypoid
lesions from the oesophagus to colon. Gut. 67:5522018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maddocks K: Update on mantle cell
lymphoma. Blood. 132:1647–1656. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jain P and Wang M: Mantle cell lymphoma:
2019 update on the diagnosis, pathogenesis, prognostication, and
management. Am J Hematol. 94:710–725. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dreyling M, Campo E, Hermine O, Jerkeman
M, Le Gouill S, Rule S, Shpilberg O, Walewski J and Ladetto M; ESMO
Guidelines Committee, : Newly diagnosed and relapsed mantle cell
lymphoma: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 28 (Suppl 4):iv62–iv71. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eyre TA, Bishton MJ, McCulloch R, O'Reilly
M, Sanderson R, Menon G, Iyengar S, Lewis D, Lambert J, Linton KM,
et al: Diagnosis and management of mantle cell lymphoma: A British
Society for Haematology Guideline. Br J Haematol. 204:108–126.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu FD, Li XP, Xu XQ, Yu H, Luo PF and
Zhou JY: Disease burden of non-Hodgkin lymphoma in Jiangsu Province
from 1990 to 2019. Pract Prev Med. 30:284–287. 2023.(In
Chinese).
|
|
11
|
Feng J, Fei Y, Gao M, Meng X, Zeng D, Zuo
D, Ye H, Liang Y, Sun X, Liang R, et al: Treatment patterns,
clinical outcomes and gene mutation characteristics of hepatitis B
virus-associated mantle cell lymphoma. Hematol Oncol. 42:e32682024.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mihăilă RG: Hepatitis C virus-Associated B
cell non-Hodgkin's lymphoma. World J Gastroenterol. 22:6214–6223.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mazzaro C, Bomben R, Gragnani L, Visentini
M, Pozzato G, Pozzo F, Zucchetto A and Gattei V: Hepatitis C
virus-associated B-cell lymphomas: The importance of the new direct
antiviral agent therapy. Semin Hematol. 59:177–182. 2022.
View Article : Google Scholar : PubMed/NCBI
|
